Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (I.R.S.T.) S.r.l.

Meldola, 47014, ItalyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Colorectal cancer

Closed trials

Completed
A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
NCT05330429· Phase 2· Gilead Sciences Inc.· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 5 Nov 2026

Report an error

Under construction, not live – Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (I.R.S.T.) S.r.l.: trial site – Frontlight Research